Medical Developments International reported AUD2.84M in Selling and Administration Expenses for its fiscal semester ending in December of 2025.





Selling And Administration Expenses Change Date
Akebia Therapeutics USD 23.53M 3.19M Dec/2025
Alaunos Therapeutics USD 424K 23K Jun/2026
Avita Medical AUD 19.54M 516K Jun/2026
Clinuvel Pharmaceuticals AUD 3.85M 5.27M Dec/2025
Dianthus Therapeutics USD 13.56M 1.09M Jun/2026
Genetic Signatures AUD 908K 31K Dec/2025
Ionis Pharmaceuticals USD 154M 23.92M Sep/2026
Medical Developments International AUD 2.84M 4.19M Dec/2025
Neuren Pharmaceuticals AUD 3.74M 2.5M Dec/2025
Organon & Co USD 407M 27M Sep/2026
PYC Therapeutics AUD 328.4K 1.8M Dec/2025
Starpharma Holdings AUD 4.42M 2.86M Dec/2025
Tectonic Therapeutic USD 6.17M 260K Jun/2026
Telix Pharmaceuticals AUD 107.02M 13.54M Jun/2026
Viatris USD 950.8M 183.7M Sep/2026
Xeris Pharmaceuticals USD 61.04M 7.89M Jun/2026